Evaluation of high volume hemofiltration according to pulse-indicated continuous cardiac output on patients with acute respiratory distress syndrome

Chinese Critical Care Medicine

Volumn 26, Issue 9, 2014, Pages 650-654

  Chen, Xiaofeng ^a   Ye, Jilu ^a   Zhu, Zhiyun ^a   Xue, Han ^a   Pu, Xuehua ^a   Miao, Xiaoli ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

Acute respiratory distress syndrome; High volume hemofiltration; Inflammatory factor; Mortality; Pulse indicated contour cardiac output monitor

Indexed keywords

INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA; LACTIC ACID; TUMOR NECROSIS FACTOR;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; ARTIFICIAL VENTILATION; BLOOD LEVEL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBEROPTIC OXIMETER CATHETER; HEART OUTPUT; HEMOFILTRATION; HIGH VOLUME HEMOFILTRATION; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LUNG COMPLIANCE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MORTALITY; OXYGENATION; PULSE INDICATED CONTINUOUS CARDIAC OUTPUT; RANDOMIZED CONTROLLED TRIAL; ARTERIAL OXYGEN TENSION; BREATHING RATE; CONSERVATIVE TREATMENT; HEMODYNAMIC PARAMETERS; INTRATHORACIC BLOOD VOLUME INDEX; LACTATE BLOOD LEVEL; LENGTH OF STAY; ORGAN FAILURE; OUTCOME ASSESSMENT; PATIENT MONITORING; PHYSICAL DISEASE; PRACTICE GUIDELINE; PROGNOSIS; PROSPECTIVE STUDY; STATIC LUNG COMPLIANCE; TREATMENT DURATION; LUNG; LUNG EXTRAVASCULAR FLUID; RESPIRATORY FUNCTION;

CARDIAC OUTPUT; EXTRAVASCULAR LUNG WATER; HEMOFILTRATION; HUMANS; INTENSIVE CARE UNITS; INTERLEUKIN-1BETA; LUNG; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY PHYSIOLOGICAL PHENOMENA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84907395269     PISSN: 10030603     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.2095-4352.2014.09.009     Document Type: Article

References (14)

1. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine[J]. Chest, 1992, 101(6):1644-1655.
2. Bone RC. Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS)[J]. Ann Intern Med, 1996, 125(8):680-687.
3. Ghani RA, Zainudin S, Ctkong N, et al. Serum IL-6 and IL-1-ra with sequential organ failure assessment scores in septic patients receiving high-volume haemofiltration and continuous venovenous haemofiltration[J]. Nephrology (Carlton), 2006, 11(5):386-393.
4. Li C, Zhang P, Cheng X, et al. High-volume hemofiltration reduces the expression of myocardial tumor necrosis factor-alpha in septic shock pigs[J]. Artif Organs, 2013, 37(2):196-202.
5. Wiedemann HP, Wheeler AP, Bernard GR, et al. Comparison of two fluid-management strategies in acute lung injury[J]. N Engl J Med, 2006, 354(24):2564-2575.
6. Sakka SG, Klein M, Reinhart K, et al. Prognostic value of extravascular lung water in critically ill patients [J]. Chest, 2002, 122(6):2080-2086.
7. Kuzkov VV, Kirov MY, Sovershaev MA, et al. Extravascular lung water determined with single transpulmonary thermodilution correlates with the severity of sepsis-induced acute lung injury[J]. Crit Care Med, 2006, 34(6):1647-1653.
8. Phillips CR, Chesnutt MS, Smith SM. Extravascular lung water in sepsis-associated acute respiratory distress syndrome: indexing with predicted body weight improves correlation with severity of illness and survival[J]. Crit Care Med, 2008, 36(1):69-73.
9. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination [J]. Am J Respir Crit Care Med, 1994, 149(3 Pt 1):818-824.
10. van Bommel EF, Hesse CJ, Jutte NH, et al. Impact of continuous hemofiltration on cytokines and cytokine inhibitors in oliguric patients suffering from systemic inflammatory response syndrome [J]. Ren Fail, 1997, 19(3):443-454.
11. Panichi V, Maggiore U, Taccola D, et al. Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients [J]. Nephrol Dial Transplant, 2004, 19(5):1154-1160.
12. Mikkelsen ME, Miltiades AN, Gaieski DF, et al. Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock[J]. Crit Care Med, 2009, 37(5):1670-1677.
13. Arnold RC, Shapiro NI, Jones AE, et al. Multicenter study of early lactate clearance as a determinant of survival in patients with presumed sepsis[J]. Shock, 2009, 32(1):35-39.
14. Jones AE, Shapiro NI, Trzeciak S, et al. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial[J]. JAMA, 2010, 303(8):739-746.